Literature DB >> 11248072

Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography.

A Karadimitris1, S Gadola, M Altamirano, D Brown, A Woolfson, P Klenerman, J L Chen, Y Koezuka, I A Roberts, D A Price, G Dusheiko, C Milstein, A Fersht, L Luzzatto, V Cerundolo.   

Abstract

CD1 molecules are specialized in presenting lipids to T lymphocytes, but identification and isolation of CD1-restricted lipid specific T cells has been hampered by the lack of reliable and sensitive techniques. We here report the construction of CD1d-glycolipid tetramers from fully denatured human CD1d molecules by using the technique of oxidative refolding chromatography. We demonstrate that chaperone- and foldase-assisted refolding of denatured CD1d molecules and beta(2)-microglobulin in the presence of synthetic lipids is a rapid method for the generation of functional and specific CD1d tetramers, which unlike previously published protocols ensures isolation of CD1d tetramers loaded with a single lipid species. The use of human CD1d-alpha-galactosylceramide tetramers for ex vivo staining of peripheral blood lymphocytes and intrahepatic T cells from patients with viral liver cirrhosis allowed for the first time simultaneous analysis of frequency and specificity of natural killer T cells in human clinical samples. Application of this protocol to other members of the CD1 family will provide powerful tools to investigate lipid-specific T cell immune responses in health and in disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248072      PMCID: PMC30647          DOI: 10.1073/pnas.051604498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.

Authors:  N Singh; S Hong; D C Scherer; I Serizawa; N Burdin; M Kronenberg; Y Koezuka; L Van Kaer
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  Oxidative refolding chromatography: folding of the scorpion toxin Cn5.

Authors:  M M Altamirano; C García; L D Possani; A R Fersht
Journal:  Nat Biotechnol       Date:  1999-02       Impact factor: 54.908

Review 3.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.

Authors:  S A Porcelli; R L Modlin
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

4.  Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

Authors:  N Burdin; L Brossay; M Kronenberg
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

5.  Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.

Authors:  C Carnaud; D Lee; O Donnars; S H Park; A Beavis; Y Koezuka; A Bendelac
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

6.  Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.

Authors:  L Brossay; O Naidenko; N Burdin; J Matsuda; T Sakai; M Kronenberg
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

7.  Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis.

Authors:  S Nuti; D Rosa; N M Valiante; G Saletti; M Caratozzolo; P Dellabona; V Barnaba; S Abrignani
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

8.  Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner.

Authors:  M Nieda; A Nicol; Y Koezuka; A Kikuchi; T Takahashi; H Nakamura; H Furukawa; T Yabe; Y Ishikawa; K Tadokoro; T Juji
Journal:  Hum Immunol       Date:  1999-01       Impact factor: 2.850

9.  CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.

Authors:  M Exley; S Porcelli; M Furman; J Garcia; S Balk
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

10.  CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.

Authors:  L Brossay; M Chioda; N Burdin; Y Koezuka; G Casorati; P Dellabona; M Kronenberg
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  55 in total

1.  Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography.

Authors:  M M Altamirano; A Woolfson; A Donda; A Shamshiev; L Briseño-Roa; N W Foster; D B Veprintsev; G De Libero; A R Fersht; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 2.  Right on target: novel approaches for the direct visualization of CD1-specific T cell responses.

Authors:  M Kronenberg; O Naidenko; F Koning
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Authors:  Markus Moll; Sofia K Andersson; Anna Smed-Sörensen; Johan K Sandberg
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

Review 4.  Harnessing invariant NKT cells in vaccination strategies.

Authors:  Vincenzo Cerundolo; Jonathan D Silk; S Hajar Masri; Mariolina Salio
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

5.  Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial.

Authors:  Mark A Exley; Phillip Friedlander; Nadia Alatrakchi; Lianne Vriend; Simon Yue; Tetsuro Sasada; Wanyong Zeng; Yo Mizukami; Justice Clark; David Nemer; Kenneth LeClair; Christine Canning; Heather Daley; Glenn Dranoff; Anita Giobbie-Hurder; F Stephen Hodi; Jerome Ritz; Steven P Balk
Journal:  Clin Cancer Res       Date:  2017-02-13       Impact factor: 12.531

6.  Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.

Authors:  Xiangshu Wen; Ping Rao; Leandro J Carreño; Seil Kim; Agnieszka Lawrenczyk; Steven A Porcelli; Peter Cresswell; Weiming Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  MHC class II-expressing thymocytes suppress invariant NKT cell development.

Authors:  Wei Li; M Hanief Sofi; Datsen G Wei; Wenjun Du; Jacquelyn Gervay-Hague; Gourapura J Renukaradhya; Randy R Brutkiewicz; Cheong-Hee Chang
Journal:  Immunol Cell Biol       Date:  2008-11-04       Impact factor: 5.126

Review 8.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

Review 9.  Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Lan Wu; Luc Van Kaer
Journal:  Expert Rev Vaccines       Date:  2008-12       Impact factor: 5.217

10.  Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans.

Authors:  You Jeong Lee; Yoon Kyung Jeon; Byung Hyun Kang; Doo Hyun Chung; Chung-Gyu Park; Hee Young Shin; Kyeong Cheon Jung; Seong Hoe Park
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.